Utama › Gangguan Depresi Major › California › Orange
Kajian klinikal Gangguan Depresi Major di Orange, CA
13 kajian untuk Gangguan Depresi Major sedang mencari peserta di lokasi dalam dan sekitar Orange (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
Mengambil pesertaFasa 3
- NRC Research Institute, Orange
A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
Mengambil pesertaFasa 2
- Nrc Research Institute, Orange
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
Mengambil pesertaFasa 3
- ATP Clinical Research, Orange
- NRC Research Institute, Orange
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
Mengambil pesertaFasa 3
- Vanda Investigational Site, Orange
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
Mengambil pesertaFasa 4
- Neurocrine Clinical Site, Orange
ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
Mengambil pesertaFasa 2
- PNS Clinical Research LLC dba ATP Clinical Research, Orange
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
Mengambil pesertaFasa 3
- ATP Clinical Research Orange County, Orange
A Study of Brenipatide in Adult Participants With Major Depressive Disorder
Mengambil pesertaFasa 3
- ATP Clinical Research, Orange
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
Mengambil pesertaFasa 3
- Atp Clinical Research, Orange
- Nrc Research Institute, Orange
A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Mengambil pesertaFasa 3
- Neurocrine Clinical Site, Orange
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Mengambil pesertaFasa 3
- Neurocrine Clinical Site, Orange
Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
Mengambil pesertaFasa 2
- Autobahn Site #152, Orange
Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Mengambil pesertaFasa 3
- Neurocrine Clinical Site, Orange
Kajian Gangguan Depresi Major di bandar lain
- New York City, NY37 kajian
- Boston, MA31 kajian
- Atlanta, GA25 kajian
- Philadelphia, PA23 kajian
- Orlando, FL19 kajian
- Miami, FL18 kajian
- Tampa, FL17 kajian
- Chicago, IL17 kajian
- Houston, TX16 kajian
- San Diego, CA16 kajian
- Little Rock, AR14 kajian
- Austin, TX13 kajian
Kajian lain di Orange
- Kanser Paru-paru Bukan Sel Kecil25 kajian
- Kanser Metastatik20 kajian
- Kanser Kolorektal16 kajian
- Kanser Ovari16 kajian
- Kanser Pankreas15 kajian
- Kanser Payudara14 kajian
- Kanser Paru-paru14 kajian
- Kanser Prostat14 kajian
- Kanser Hati (Karsinoma Hepatoselular)14 kajian
- Melanoma14 kajian
- Leukemia Mieloid Akut13 kajian
- Kanser (semua jenis)13 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.